261 filings
Page 2 of 14
8-K
tqo7acseuax
8 Jan 24
Departure of Directors or Certain Officers
6:45am
DEFA14A
u5086
19 Dec 23
Additional proxy soliciting materials
8:32am
SC TO-C
4wt5g27gazo0dja y0
8 Dec 23
Information about tender offer
9:00am
PRE 14A
sjhbe5fy 33
8 Dec 23
Preliminary proxy
8:30am
8-K
z7hn1q
7 Nov 23
Entry into a Material Definitive Agreement
7:39am
424B5
k4l47ga4
7 Nov 23
Prospectus supplement for primary offering
7:29am
8-K
uz0x7pn
7 Nov 23
Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
cgnwjjy bvtjzt
31 Aug 23
Cost Associated with Exit or Disposal Activities
6:45am
S-8
0b2jjsuwz5v2ldjv6j
7 Aug 23
Registration of securities for employees
7:49am
8-K
4vlzak810r7c9y
7 Aug 23
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
414py9b u3cz
16 Jun 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
xq6us2cqrwtxee
7 Jun 23
Additional proxy soliciting materials
4:05pm
8-K
uy164e6lihavi4bi7
2 May 23
Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
ARS
gdjkt oblca23ya0
27 Apr 23
Annual report to shareholders
4:11pm
DEFA14A
fm56r96
27 Apr 23
Additional proxy soliciting materials
4:08pm